Beta Bionics (BBNX) Competitors $14.00 -0.50 (-3.45%) As of 01:28 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends BBNX vs. WRBY, TMDX, LIVN, NVCR, ENOV, SLNO, LMAT, CNMD, INMD, and CDREShould you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include Warby Parker (WRBY), TransMedics Group (TMDX), LivaNova (LIVN), NovoCure (NVCR), Enovis (ENOV), Soleno Therapeutics (SLNO), LeMaitre Vascular (LMAT), CONMED (CNMD), InMode (INMD), and Cadre (CDRE). These companies are all part of the "medical equipment" industry. Beta Bionics vs. Warby Parker TransMedics Group LivaNova NovoCure Enovis Soleno Therapeutics LeMaitre Vascular CONMED InMode Cadre Warby Parker (NYSE:WRBY) and Beta Bionics (NASDAQ:BBNX) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, community ranking, valuation, analyst recommendations, dividends, media sentiment, earnings and risk. Which has preferable valuation and earnings, WRBY or BBNX? Beta Bionics has lower revenue, but higher earnings than Warby Parker. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$771.32M2.74-$63.20M-$0.17-120.14Beta Bionics$53.03M11.72N/AN/AN/A Do insiders and institutionals have more ownership in WRBY or BBNX? 93.2% of Warby Parker shares are owned by institutional investors. 26.5% of Warby Parker shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is WRBY or BBNX more profitable? Beta Bionics has a net margin of 0.00% compared to Warby Parker's net margin of -4.39%. Beta Bionics' return on equity of 0.00% beat Warby Parker's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-4.39% -8.26% -4.37% Beta Bionics N/A N/A N/A Does the media favor WRBY or BBNX? In the previous week, Warby Parker had 5 more articles in the media than Beta Bionics. MarketBeat recorded 8 mentions for Warby Parker and 3 mentions for Beta Bionics. Warby Parker's average media sentiment score of 1.01 beat Beta Bionics' score of 0.19 indicating that Warby Parker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beta Bionics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer WRBY or BBNX? Warby Parker received 38 more outperform votes than Beta Bionics when rated by MarketBeat users. However, 66.67% of users gave Beta Bionics an outperform vote while only 43.56% of users gave Warby Parker an outperform vote. CompanyUnderperformOutperformWarby ParkerOutperform Votes4443.56% Underperform Votes5756.44% Beta BionicsOutperform Votes666.67% Underperform Votes333.33% Do analysts rate WRBY or BBNX? Warby Parker presently has a consensus target price of $23.43, suggesting a potential upside of 14.71%. Beta Bionics has a consensus target price of $24.83, suggesting a potential upside of 71.26%. Given Beta Bionics' stronger consensus rating and higher possible upside, analysts clearly believe Beta Bionics is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 6 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.69Beta Bionics 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78 SummaryWarby Parker and Beta Bionics tied by winning 7 of the 14 factors compared between the two stocks. Remove Ads Get Beta Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBNX vs. The Competition Export to ExcelMetricBeta BionicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$621.46M$4.31B$5.64B$8.08BDividend YieldN/A39.84%4.89%4.04%P/E RatioN/A28.1623.7418.99Price / Sales11.7250.26381.75120.64Price / CashN/A51.0838.0534.64Price / BookN/A6.086.904.26Net IncomeN/A$67.09M$3.18B$247.00M7 Day Performance-18.59%-1.10%6.75%-1.60%1 Month Performance-33.33%-10.31%0.16%-9.68%1 Year PerformanceN/A19.61%13.61%1.96% Beta Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBNXBeta BionicsN/A$13.96-3.7%$24.83+77.9%N/A$598.31M$53.03M0.00294Quiet Period ExpirationGap UpWRBYWarby Parker3.1519 of 5 stars$21.61-8.1%$23.43+8.4%+78.2%$2.44B$771.32M-80.023,491TMDXTransMedics Group3.0389 of 5 stars$65.29-3.2%$122.70+87.9%-20.8%$2.20B$441.54M69.46210Analyst ForecastShort Interest ↓Gap DownLIVNLivaNova4.0412 of 5 stars$39.99-2.2%$62.20+55.5%-24.8%$2.17B$1.25B95.212,900Short Interest ↓NVCRNovoCure3.6011 of 5 stars$19.26+0.6%$32.67+69.6%+34.9%$2.12B$605.22M-13.761,453ENOVEnovis2.5872 of 5 stars$37.12-1.3%$58.50+57.6%-40.8%$2.11B$2.11B-16.956,550SLNOSoleno Therapeutics3.9819 of 5 stars$44.94-0.1%$71.20+58.4%+6.5%$1.94BN/A-13.5430LMATLeMaitre Vascular3.2478 of 5 stars$82.49-5.2%$95.25+15.5%+23.1%$1.85B$219.86M45.08490Positive NewsHigh Trading VolumeCNMDCONMED4.794 of 5 stars$59.14+2.7%$77.20+30.5%-30.5%$1.83B$1.31B13.954,000INMDInMode1.6381 of 5 stars$19.31+0.3%$22.25+15.2%-15.4%$1.34B$394.82M8.22480News CoverageCDRECadre1.849 of 5 stars$32.97+0.5%$37.00+12.2%-10.0%$1.33B$516.16M39.732,435Earnings ReportNews Coverage Remove Ads Related Companies and Tools Related Companies Warby Parker Competitors TransMedics Group Competitors LivaNova Competitors NovoCure Competitors Enovis Competitors Soleno Therapeutics Competitors LeMaitre Vascular Competitors CONMED Competitors InMode Competitors Cadre Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBNX) was last updated on 3/13/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
